Frontlight ResearchEarly access
Trial site
Hacettepe Universitesi Kanser Enstitusu
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- BioNTech SE1 trial
- Jazz Pharmaceuticals1 trial
- Mirati Therapeutics Inc.1 trial
- Taiho Oncology, Inc.1 trial
Running trials
Active, not recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026